APPLICATIONS PUBLISHED 15 SEPTEMBER 2004
Published: 1-Apr-2005
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Novel use of apple core extracts in cosmetic or pharmaceutical compsns
Henkel Kommanditgesellschaft auf Aktien 1455749*
Viscoelastic ophthalmic compsns comprising hyaluronic acid
Alcon 1455750*
Zero-order sustained release dosage forms and method of making the same
Pharmacia 1455751*
Pharmaceutical suspension for oral administration
Pharmacia 1455752*
Pharmaceutical compsns comprising a cyclosporin, a hydrophilic surfactant and a lipophilic surfactant
Sherman, Bernard Charles 1455753*
Pharmaceutical compsns in particulate form
Becton, Dickinson & Company 1455754*
Improved particulate compsns for pulmonary delivery
Advanced Inhalation Research 1455755*
Pharmaceutical nanoparticulate compsn of a tachykinin receptor antagonist
Merck 1455756*
Methods for wet granulating azithromycin
Pfizer 1455757*
Directly compressible formulations of azithromycin
Pfizer 1455758*
Pharmaceutical compsn for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
Peirce Management 1455759*
Ultrapure oral fludara formulation with a fast releasing active substance
Schering 1455760*
Pharmaceutical compsn for the oral administration of heparin or derivatives thereof
Cosmo 1455761*
Solid formulation producing carbon dioxide when contacting liquid acid and a method of preparing the same
Kim, Yong-Nyun 1455762*
Oral capsule formulation with increased physical stability
Shire Laboratories 1455763*
Medicinal aerosol compsns, with an amide and/or ester containing excipient compound
3M Innovative Properties 1455764*
Use of protease-activated receptor-2 inhibitor in the manufacture of a medicament for treating delayed hypersensitivity
Kowa 1455765*
Thymosin alpha-1 peptide/polymer conjugates
SciClone Pharmaceuticals 1455766*
Method and compsns for treating respiratory pathologies
Rytek 1455767*
Respiratory infection prevention and treatment with terpene-containing compsns
Eden Research 1455768*
Processes for preparing crystalline and amorphous mupirocin calcium
Biogal Gyogyszergyar 1455769*
Use of norepinephrine reuptake inhibitors for the treatment of TIC disorders
Eli Lilly 1455770*
2-indanylamino derivatives for the therapy of chronic pain
Chiesi Farmaceutici 1455771*
Medium for radical treatment of tumours, inflammatory processes, fungal infections and other affections of the tissues, diagnostic and prophylactic and method of its implementation
Panchev, Vladimir 1455772*
2-aryl-propionic acids and pharmaceutical compsns containing them
Dompe 1455773*
Pharmaceutical compsn for treating obesity
Lean-Ex 1455774*
Methods and compsns for modulating the immune system and uses thereof
Dana-Farber Cancer Institute 1455775*
A non-arrhythmogenic metabolite of oxybutynin
Bridge Pharma 1455776*
GLYT1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
SmithKline Beecham 1455777*
Methods for the treatment of peripheral neural and vascular ailments
The Quigley Corp 1455778*
Indolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands
Wyeth 1455779*
Novel benodifuranimidazoline and benzofuranimidazoline derivatives and their use for the treatment of glaucoma
Alcon 1455780*
Use of anastrozole for the treatment of post-menopausal women having early breast cancer
AstraZeneca 1455781*
High-concentration stable meloxicam solutions for needle-less injection
Boehringer Ingelheim Vetmedica 1455782*
Combination of a selective PE4 inhibitor and an adrenergic beta-2 receptor agonist
Pfizer 1455783*
Analgesic delivery systems and methods of use
Aryx Therapeutics 1455784*
Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
Bayer HealthCare 1455785*
Use of a compound in the treatment of sleep disorders and the like in providing refreshedness on waking and a method for the treatment of grogginess therewith
The Boots Company 1455786*
Certain glycine derivatives as factor XA inhibitors for use in the treatment of thrombotic disorders
Eli Lilly 1455789*
Use of pyridine-2,4-dicarboxylic acid diamines and of pyrimidine-4,6-dicarboxylic acid diamides for selective collagenase inhibition
Aventis Pharma Deutschland 1455790*
Method for administering BIRB 796 BS
Boehringer Ingelheim Pharmaceuticals 1455791*
Ureas of 2-aminobenzothiazoles as adenosine modulators
F Hoffmann-La Roche 1455792*
Antidiabetic formulation and method
Bristol-Myers Squibb 1455793*
Pharmaceutical compsn comprising a CLC-2 channel opener
Sucampo 1455794*
Method of treating ophthalmic disorders with epoxy-steroidal aldosterone receptor antagonists
Pharmacia 1455795*
Method for the treatment of bone disorders
Procter & Gamble 1455796*
Pseudopterosin compounds of symbiodinium spp isolated from Pseudopterogorgia elisabethae
The Regents of the University of California 1455797*
Phosphorothioate-modified oligonucleotide as anti-restenosis agent
Cube Medical; Centre National de la Recherche Scientifique 1455798*
Pharmaceutical combinations of adenosine A-2A and beta-2-adrenergic receptor agonists
Pfizer 1455799*
Process for the preparation of glucosamine salts
Bioiberica 1455800*
Ribavirin granulate for producing coated tablets
Biopartners 1455801*
Chitosan oligosaccharides and uses thereof
ISM Biopolymer 1455802*
Pharmaceutical compsn for use in ophthalmology and rhinology
Ursapharm Arzneimittel 1455803*
Use of nanoparticles as carriers for biocides in ophthalmic compsns
Alcon 1455804*
A procedure for obtaining a zinc oxide containing product for skin-healing, care and protection in children and adults
Pavlovic, Vojislav 1455805*
Active agent mixture containing a plant extract of convolvulacaea for treating hair problems, skin disorders and skin diseases
Kalander Barzinjy 1455806*
Method for use of IGF-binding protein for selective sensitisation of target cells in vivo
Bioexpertise 1455807*
Phosphinate-peptide analogues as inhibitors of procollagen-C-proteinase (PCP) for treating fibrotic diseases
Burchardt, Elmar 1455808*
Inhibitors of hepatitis C virus
Bristol-Myers Squibb 1455809*
Pharmaceutical formulation comprising cyclosporin and use thereof
Jagotec 1455810*
Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof
Ludwig Institute for Cancer Research 1455811*
Antagonist anti-CD40 monoclonal antibody therapy for multiple sclerosis treatment
Chiron Corp 1455812*
Pharmaceutical compsn of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung disease
Mondobiotech Laboratories Anstalt 1455813*
Pharmaceutical compsns comprising unacylated ghrelin and therapeutic uses thereof
Theratechnologies 1455814*
Human diacylglycerol acyltransferase 2 (DHAT2) family members and uses therefor
Millennium Pharmaceuticals 1455815*
Staphylococcus aureus exopolysaccharide and process
Merck 1455817*
Applications of spores
King's College London 1455818*
Individualised anti-cancer antibodies
Arius Research 1455819*
Targeted ligands
Herman, William 1455820*
Parathyroid hormone antibodies and related methods
Quest Diagnostics Investments 1455821*
Lyophilised monoclonal antibody compsns
Centocor 1455822*
Anti-T cell immunotoxin fusion protein and its therapeutic use
Novartis 1455823*
Lyophilised preparation containing antibodies to the EGF receptor
Merck Patent 1455824*
Treating B-cell mediated diseases by modulating DR6 activity
Eli Lilly 1455825*
Combination comprising anti-CD52 antibodies and other therapeutic agents for treatment of multiple sclerosis
Ilex Oncology 1455826*
Pecam-1 modulation
The University of Reading 1455827*
Photosensitiser functionalised nanoparticles
University of East Anglia 1455828*
Treating vascular disease by inhibiting myeloid differentiation factor 88
Cedars-Sinai Medical Centre 1455829*
Selective anaesthetic agents and methods of identifying the same
Merck Sharp & Dohme 1455830*
Method of controlling ovarian hyperstimulation and pharmaceutical kit for use in such methods
Pantarhei Bioscience 1455831*
Pulsed bioagent delivery systems based on degradable polymer solutions of hydrogels
Universiteit Gent 1455832*
Chimeric molecule for the treatment of TH2-like cytokine mediated disorders
The Government of the United States of America, represented by the Department of Health and Human Services 1455833*
Post-coated liposome/lipoplex for targeted drug/gene delivery and lipid linked to a delivery, targeting or stabilising moiety
Mitsubishi Chemical 1455834*
Method of modulating release of saccharides and uses thereof
ISM Biopolymer 1455835*
Use of micro-organisms for a directed delivery of substances to specific parts of the gut
Societe des Produits Nestle 1455836*
Pharmaceutical conjugates with enhanced pharmacokinetic characteristics
Allergan 1455837*
Process for preparation of inclusion compounds between a non-steroidal anti-inflammatory drug and betacyclodextrin by microwave treatment
Chiesi Farmaceutici 1455838*
Heterobifunctional poly(ethylene glycol) derivatives and methods for the preparation thereof
Nektar Therapeutics 1455839*
Treatment of human cancer with adenoviral vector expressing TNF-alpha
Genvec 1455840*
